CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Introgen Therapeutics

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Feb 1, 2006

Defunct as of May 17, 2010

Timeline

1990s

Jun 1, 1993
Introgen Therapeutics— Founded

2010s

May 17, 2010
Introgen Therapeutics— Defunct

Drugs by trial phase (3 distinct, 5 trials)

Phase 3 (1 own, 0 via acquisition)

ingn 201

Phase 2 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (6)

NCT00286247Lead sponsorPhase 2Feb 1, 2006
NCT00116363Lead sponsorPhase 2Mar 1, 2005
NCT00041626Lead sponsorPhase 3Jul 11, 2002
NCT00041613Lead sponsorPhase 3Jul 11, 2002
NCT00044993Study chairPhase 2Feb 1, 2002
NCT00044993Lead sponsorPhase 2Feb 1, 2002

Details

Founded: Austin, TX, US Jun 1, 1993
Last known activity: Feb 1, 2006